AAAAAA

   
Results: 1-17 |
Results: 17
A PHASE-I STUDY OF XR5000 (DACA) BY 120 HOUR INTRAVENOUS-INFUSION
Authors: DEBONO JS PROPPER D ELLARD S STEINER J BEVAN P DOBBS N FLANAGAN E GANESAN TS TALBOT DC CAMPBELL S TWELVES C HARRIS A
Citation: Js. Debono et al., A PHASE-I STUDY OF XR5000 (DACA) BY 120 HOUR INTRAVENOUS-INFUSION, Annals of oncology, 9, 1998, pp. 449-449
REVERSAL OF P-GLYCOPROTEIN-MEDIATED MULTIDRUG-RESISTANCE BY XR9051, ANOVEL DIKETOPIPERAZINE DERIVATIVE
Authors: DALE IL TUFFLEY W CALLAGHAN R HOLMES JA MARTIN K LUSCOMBE M MISTRY P RYDER H STEWART AJ CHARLTON P TWENTYMAN PR BEVAN P
Citation: Il. Dale et al., REVERSAL OF P-GLYCOPROTEIN-MEDIATED MULTIDRUG-RESISTANCE BY XR9051, ANOVEL DIKETOPIPERAZINE DERIVATIVE, British Journal of Cancer, 78(7), 1998, pp. 885-892
XR5118, A NOVEL MODULATOR OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1), INCREASES ENDOGENOUS TPA ACTIVITY IN THE RAT
Authors: CHARLTON P FAINT R BARNES C BENT F FOLKES A TEMPLETON D MACKIE I MACHIN S BEVAN P
Citation: P. Charlton et al., XR5118, A NOVEL MODULATOR OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1), INCREASES ENDOGENOUS TPA ACTIVITY IN THE RAT, Fibrinolysis & proteolysis, 11(1), 1997, pp. 51-56
A NOVEL LOW-MOLECULAR-WEIGHT INHIBITOR OF PAI-1 (XR5118) PREVENTS BPAPAI-1 COMPLEX-FORMATION AND SELECTIVELY INTERFERES WITH A T-PA BINDING-SITE ON PAI-I/
Authors: FRIEDERICH PW LEVI M CHARLTON P BIEMOND BJ BROOKS T FAINT R TEMPLETON D BEVAN P VANZONNEVELD AJ PANNEKOEK H
Citation: Pw. Friederich et al., A NOVEL LOW-MOLECULAR-WEIGHT INHIBITOR OF PAI-1 (XR5118) PREVENTS BPAPAI-1 COMPLEX-FORMATION AND SELECTIVELY INTERFERES WITH A T-PA BINDING-SITE ON PAI-I/, Thrombosis and haemostasis, 1997, pp. 1450-1450
REGULATION OF NEURONAL AND RECOMBINANT GABA(A) RECEPTOR-ION CHANNELS BY XENOVULENE-A, A NATURAL PRODUCT ISOLATED FROM ACREMONIUM-STRICTUM
Authors: THOMAS P SUNDARAM H KRISHEK BJ CHAZOT P XIE X BEVAN P BROCCHINI SJ LATHAM CJ CHARLTON P MOORE M LEWIS SJ THORNTON DM STEPHENSON FA SMART TG
Citation: P. Thomas et al., REGULATION OF NEURONAL AND RECOMBINANT GABA(A) RECEPTOR-ION CHANNELS BY XENOVULENE-A, A NATURAL PRODUCT ISOLATED FROM ACREMONIUM-STRICTUM, The Journal of pharmacology and experimental therapeutics, 282(2), 1997, pp. 513-520
NOVEL LOW-MOLECULAR-WEIGHT INHIBITOR OF PAI-1 (XR5118) PROMOTES ENDOGENOUS FIBRINOLYSIS AND REDUCES POSTTHROMBOLYSIS THROMBUS GROWTH IN RABBITS
Authors: FRIEDERICH PW LEVI M BIEMOND BJ CHARLTON P TEMPLETON D VANZONNEVELD AJ BEVAN P PANNEKOEK H TENCATE JW
Citation: Pw. Friederich et al., NOVEL LOW-MOLECULAR-WEIGHT INHIBITOR OF PAI-1 (XR5118) PROMOTES ENDOGENOUS FIBRINOLYSIS AND REDUCES POSTTHROMBOLYSIS THROMBUS GROWTH IN RABBITS, Circulation, 96(3), 1997, pp. 916-921
EVALUATION OF A LOW-MOLECULAR-WEIGHT MODULATOR OF HUMAN PLASMINOGEN-ACTIVATOR INHIBITOR-1 ACTIVITY
Authors: CHARLTON PA FAINT RW BENT F BRYANS J CHICARELLIROBINSON I MACKIE I MACHIN S BEVAN P
Citation: Pa. Charlton et al., EVALUATION OF A LOW-MOLECULAR-WEIGHT MODULATOR OF HUMAN PLASMINOGEN-ACTIVATOR INHIBITOR-1 ACTIVITY, Thrombosis and haemostasis, 75(5), 1996, pp. 808-815
EFFECTS OF XR5118 ON PAI-1 AND TPA ACTIVITY AND ARTERIAL THROMBUS FORMATION IN THE ANESTHETIZED RAT
Authors: BARNES CS FAINT RW DWYER MC CRITCHLEY DJP TEMPLETON D FOLKES AJ CHARLTON PA BEVAN P
Citation: Cs. Barnes et al., EFFECTS OF XR5118 ON PAI-1 AND TPA ACTIVITY AND ARTERIAL THROMBUS FORMATION IN THE ANESTHETIZED RAT, British Journal of Pharmacology, 118, 1996, pp. 97-97
XENOVULENE-A, A NOVEL COMPOUND ACTIVE AT GABA, RECEPTORS - FUNCTIONAL-STUDIES ON EXPRESSED RECOMBINANT AND MAMMALIAN NEURONAL GABA(A) RECEPTORS
Authors: THOMAS P SUNDARAM H KRISHEK BJ LATHAM CJ BEVAN P STEPHENSON FA SMART TG
Citation: P. Thomas et al., XENOVULENE-A, A NOVEL COMPOUND ACTIVE AT GABA, RECEPTORS - FUNCTIONAL-STUDIES ON EXPRESSED RECOMBINANT AND MAMMALIAN NEURONAL GABA(A) RECEPTORS, British Journal of Pharmacology, 117, 1996, pp. 299-299
XENOVULENE-A, A NOVEL COMPOUND ACTIVE AT GABA(A) RECEPTORS - CHARACTERIZATION BY RADIOLIGAND BINDING
Authors: SUNDARAM H THOMAS P CHAZOT PL LATHAM C BEVAN P SMART TG STEPHENSON FA
Citation: H. Sundaram et al., XENOVULENE-A, A NOVEL COMPOUND ACTIVE AT GABA(A) RECEPTORS - CHARACTERIZATION BY RADIOLIGAND BINDING, British Journal of Pharmacology, 117, 1996, pp. 300-300
INACTIVATION OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) BY XR5118
Authors: FAINT R CHARLTON P TEMPLETON D BENT F FOLKES A MACKIE I MACHIN S BEVAN P
Citation: R. Faint et al., INACTIVATION OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) BY XR5118, Blood, 88(10), 1996, pp. 1121-1121
A SERIES OF LOW-MOLECULAR-WEIGHT INHIBITORS OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) INCREASE FIBRINOLYSIS AND PROTECT AGAINST THROMBUSFORMATION IN THE RAT
Authors: CHARLTON PA FAINT RW BENT F BRYANS J MACKIE I MACHIN S BEVAN P
Citation: Pa. Charlton et al., A SERIES OF LOW-MOLECULAR-WEIGHT INHIBITORS OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) INCREASE FIBRINOLYSIS AND PROTECT AGAINST THROMBUSFORMATION IN THE RAT, Thrombosis and haemostasis, 73(6), 1995, pp. 1005-1005
THE IN-VITRO EVALUATION OF A SERIES OF LOW-MOLECULAR-WEIGHT INHIBITORS OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1)
Authors: FAINT RW CHARLTON PA BENT F BRYANS J MACKIE I MACHIN S BEVAN P
Citation: Rw. Faint et al., THE IN-VITRO EVALUATION OF A SERIES OF LOW-MOLECULAR-WEIGHT INHIBITORS OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1), Thrombosis and haemostasis, 73(6), 1995, pp. 1007-1007
IDENTIFYING SMALL-MOLECULE LEAD COMPOUNDS - THE SCREENING APPROACH TODRUG DISCOVERY
Authors: BEVAN P RYDER H SHAW A
Citation: P. Bevan et al., IDENTIFYING SMALL-MOLECULE LEAD COMPOUNDS - THE SCREENING APPROACH TODRUG DISCOVERY, Trends in biotechnology, 13(3), 1995, pp. 115-121
EVALUATION OF A LOW-MOLECULAR-WEIGHT INHIBITOR OF PLASMINOGEN-ACTIVATOR INHIBITOR-1
Authors: CHARLTON PA BARNES CS BENT FM BRYANS JS FAINT RW FOLKES AJ MACHIN SJ MACKIE I BEVAN P
Citation: Pa. Charlton et al., EVALUATION OF A LOW-MOLECULAR-WEIGHT INHIBITOR OF PLASMINOGEN-ACTIVATOR INHIBITOR-1, Circulation, 92(8), 1995, pp. 2320-2320
THE CHARACTERIZATION OF A NOVEL INHIBITOR OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) IN-VITRO
Authors: FAINT RW CHARLTON P BENT F BRYANS J MACKIE I BEVAN P
Citation: Rw. Faint et al., THE CHARACTERIZATION OF A NOVEL INHIBITOR OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) IN-VITRO, Blood, 84(10), 1994, pp. 10000073-10000073
A LOW-MOLECULAR-WEIGHT INHIBITOR OF PLASMINOGEN-ACTIVATOR INHIBITOR-1(PAI-1) INCREASES FIBRINOLYSIS IN THE RAT
Authors: CHARLTON P FAINT RW BENT F BRYANS J MACKIE I BEVAN P
Citation: P. Charlton et al., A LOW-MOLECULAR-WEIGHT INHIBITOR OF PLASMINOGEN-ACTIVATOR INHIBITOR-1(PAI-1) INCREASES FIBRINOLYSIS IN THE RAT, Blood, 84(10), 1994, pp. 10000245-10000245
Risultati: 1-17 |